Cargando…
Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries
The increasing availability of biosimilar medicines in Middle Eastern regions may provide an opportunity to increase the number of rheumatology patients who have access to traditionally more expensive biologic medicines. However, as well as a lack of real-world data on the use of biosimilar medicine...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913383/ https://www.ncbi.nlm.nih.gov/pubmed/29411181 http://dx.doi.org/10.1007/s10067-018-3982-9 |